Search

Your search keyword '"Trapin, Doris"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Trapin, Doris" Remove constraint Author: "Trapin, Doris" Database Unpaywall Remove constraint Database: Unpaywall
22 results on '"Trapin, Doris"'

Search Results

1. Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains

2. Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3

3. The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg

4. Mycobacterium avium Complex Infections: Detailed Phenotypic and Functional Immunological Work-Up Is Required despite Genetic Analyses

5. Combined assessment of S‐ and N‐specific IL ‐2 and IL ‐13 secretion and CD69 neo‐expression for discrimination of post–infection and post‐vaccination cellular SARS‐CoV ‐2‐specific immune response

6. Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants

7. Omicron: A SARS‐CoV‐2 variant of real concern

8. Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma

9. Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes

10. Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination

11. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses

12. Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations

13. Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding

16. Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro

17. Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model

18. Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice

19. Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation

Catalog

Books, media, physical & digital resources